931100381	931100381	CD	B-NP	O
|	|	NN	I-NP	O
SPN	SPN	NN	I-NP	O
|	|	NN	I-NP	O
74802632	74802632	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3838808	3838808	CD	B-NP	O
|	|	CC	I-NP	O
8/21/2006	8/21/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
RESPIRATORY	RESPIRATORY	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/9/2006	10/9/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/13/2006	9/13/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
SPIOTTA	SPIOTTA	NN	B-NP	B-protein
,	,	,	O	O
GERMAN	GERMAN	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
General	General	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Aspiration	Aspiration	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

PROBLEMS	PROBLEMS	NNS	B-NP	O
:	:	:	O	O
Diabetes	Diabete	NNS	B-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
thrombocytopenia	thrombocytopenia	NN	B-NP	O
,	,	,	O	O
elevated	elevated	JJ	B-NP	O
LFTs	LFT	NNS	I-NP	O
,	,	,	O	O
agitation	agitation	NN	B-NP	O
,	,	,	O	O
aspiration	aspiration	NN	B-NP	O
and	and	CC	O	O
rheumatoid	rheumatoid	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Vinzant	Vinzant	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
71-year-old	71-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
obesity	obesity	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
hypercarbic	hypercarbic	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
failure	failure	NN	I-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
facility	facility	NN	I-NP	O
for	for	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
shallow	shallow	NN	I-NP	O
breathing	breathing	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
arrival	arrival	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
hypoxic	hypoxic	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
hypoglycemic	hypoglycemic	JJ	I-ADJP	O
,	,	,	O	O
responding	respond	VBG	B-VP	O
to	to	TO	B-PP	O
fluids	fluid	NNS	B-NP	O
,	,	,	O	O
intubation	intubation	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
transferred	transfer	VBN	I-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
medical	medical	JJ	I-NP	O
ICU	ICU	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
general	general	JJ	I-NP	O
medical	medical	JJ	I-NP	O
floor	floor	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
admission	admission	NN	I-NP	O
to	to	TO	B-PP	O
Th	Th	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
for	for	IN	B-PP	O
sepsis	sepsis	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
cellulitis	cellulitis	NN	B-NP	O
and	and	CC	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
,	,	,	O	O
enjoying	enjoy	VBG	B-VP	O
that	that	IN	B-SBAR	O
admission	admission	NN	B-NP	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
ATN	ATN	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
antibiotic	antibiotic	JJ	B-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

ROS	ROS	NNS	B-NP	O
on	on	IN	B-PP	O
arrival	arrival	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
medicine	medicine	NN	I-NP	O
floor	floor	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
possible	possible	JJ	B-ADJP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
disoriented	disorient	VBN	I-VP	O
-LRB-	-LRB-	NN	B-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
report	report	VB	I-VP	O
low	low	JJ	B-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
chronic	chronic	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
moaning	moan	VBG	I-VP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
stroke/aphasia	stroke/aphasia	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
but	but	CC	O	O
appears	appear	VBZ	B-VP	O
in	in	IN	B-PP	O
NAD	NAD	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

COPD	COPD	NN	B-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
uses	use	VBZ	B-VP	O
BiPAP	BiPAP	NN	B-NP	B-protein
at	at	IN	B-PP	O
home	home	NN	B-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
oxygen	oxygen	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

Ejection	Ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
is	be	VBZ	B-VP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
elevated	elevated	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
artery	artery	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
of	of	IN	B-PP	O
57	57	CD	B-NP	O
above	above	IN	B-PP	O
rate	rate	NN	B-NP	O
reduction	reduction	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Obstructive	Obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
with	with	IN	B-PP	O
Pickwickian	Pickwickian	JJ	B-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Sick	Sick	NN	B-NP	O
sinus	sinus	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
implantation	implantation	NN	I-NP	O
in	in	IN	B-PP	O
2000	2000	CD	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Angina	Angina	NNP	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
septal	septal	JJ	I-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Hyperlipidemia	Hyperlipidemia	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
type	type	NN	I-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
recently	recently	RB	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
insulin	insulin	NN	B-NP	B-protein
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
stress	stress	NN	B-NP	O
dose	dose	NN	I-NP	O
steroids	steroid	NNS	I-NP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
last	last	JJ	I-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Osteoporosis	Osteoporosis	NN	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Rheumatoid	Rheumatoid	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

GERD	GERD	NN	B-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Cellulitis	Cellulitis	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Thrombocytopenia	Thrombocytopenia	NNP	B-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Iron	Iron	NN	B-NP	O
deficiency	deficiency	NN	I-NP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

CVA	CVA	NN	B-NP	O
in	in	IN	B-PP	O
1998	1998	CD	B-NP	O
with	with	IN	B-PP	O
expressive	expressive	JJ	B-NP	O
aphasia	aphasia	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Fluconazole	Fluconazole	NN	B-NP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
atorvastatin	atorvastatin	NN	B-NP	O
,	,	,	O	O
Imdur	Imdur	NNP	B-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
,	,	,	O	O
Norvasc	Norvasc	NNP	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
,	,	,	O	O
Advair	Advair	NNP	B-NP	O
,	,	,	O	O
DuoNebs	DuoNebs	NNP	B-NP	O
,	,	,	O	O
multivitamin	multivitamin	NN	B-NP	O
,	,	,	O	O
folate	folate	NN	B-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
,	,	,	O	O
Lispro	Lispro	NNP	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
,	,	,	O	O
senna	senna	NN	B-NP	O
,	,	,	O	O
Colace	Colace	NN	B-NP	O
and	and	CC	I-NP	O
oxycodone	oxycodone	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
her	her	PRP	B-NP	O
Healthcare	Healthcare	NNP	I-NP	O
Proxy	Proxy	NNP	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Noncontributory	Noncontributory	JJ	B-ADJP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
temperature	temperature	NN	B-NP	B-protein
99.1	99.1	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
69	69	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
149/77	149/77	CD	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
of	of	IN	B-PP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
nonrebreather	nonrebreather	NN	I-NP	O
.	.	.	O	O

Morbidly	Morbidly	RB	B-ADJP	O
obese	obese	JJ	I-ADJP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
examination	examination	NN	I-NP	O
is	be	VBZ	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
fixed	fix	VBN	B-NP	O
left	left	JJ	I-NP	O
pupil	pupil	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
surgery	surgery	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
pinpoint	pinpoint	NN	I-NP	O
right	right	JJ	I-NP	O
pupil	pupil	NN	I-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
can	can	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
assessed	assess	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
obesity	obesity	NN	B-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
exam	exam	NN	I-NP	O
is	be	VBZ	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
diffuse	diffuse	JJ	B-NP	O
rhonchi	rhonchus	NNS	I-NP	O
with	with	IN	B-PP	O
wheezing	wheeze	VBG	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
examination	examination	NN	I-NP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
2/6	2/6	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
reveal	reveal	VBP	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	B-NP	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
STUDIES	STUDIES	NNS	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
were	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
sodium	sodium	NN	B-NP	O
of	of	IN	B-PP	O
149	149	CD	B-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
49	49	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
2.3	2.3	CD	B-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
of	of	IN	B-PP	O
21	21	CD	B-NP	O
,	,	,	O	O
white	white	JJ	B-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
13	13	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
34	34	CD	B-NP	O
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
63	63	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
alkaline	alkaline	NN	I-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
of	of	IN	B-PP	O
284	284	CD	B-NP	O
,	,	,	O	O
ALT	ALT	NN	B-NP	O
of	of	IN	B-PP	O
82	82	CD	B-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
of	of	IN	B-PP	O
4.0	4.0	CD	B-NP	O
,	,	,	O	O
direct	direct	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
of	of	IN	B-PP	O
2.0	2.0	CD	B-NP	O
,	,	,	O	O
albumin	albumin	NN	B-NP	O
of	of	IN	B-PP	O
2.5	2.5	CD	B-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
of	of	IN	B-PP	O
2.1	2.1	CD	B-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
reveals	reveal	VBZ	B-VP	O
a	a	DT	B-NP	O
RLL	RLL	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Aspiration	Aspiration	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
grew	grow	VBD	B-VP	O
MRSA	MRSA	NN	B-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
sputum	sputum	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	I-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
extubated	extubate	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
first	first	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
day	day	NN	I-NP	O
after	after	IN	B-PP	O
arriving	arrive	VBG	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
aspirate	aspirate	VB	I-VP	O
and	and	CC	O	O
failed	fail	VBD	B-VP	O
a	a	DT	B-NP	O
bedside	bedside	NN	I-NP	O
swallow	swallow	NN	I-NP	O
study	study	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
stabilized	stabilize	VBN	I-VP	O
and	and	CC	O	O
transported	transport	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
medicine	medicine	NN	I-NP	O
floor	floor	NN	I-NP	O
on	on	IN	B-PP	O
overnight	overnight	JJ	B-NP	O
BiPAP	BiPAP	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
again	again	RB	B-ADVP	O
failed	fail	VBD	B-VP	O
bedside	bedside	NN	B-NP	O
swallow	swallow	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
with	with	IN	B-PP	O
thin	thin	JJ	B-NP	O
liquids	liquid	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
therefore	therefore	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
conservative	conservative	JJ	I-NP	O
pudding	pudde	VBG	I-NP	O
thick	thick	JJ	I-NP	O
puree	puree	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
aspirate	aspirate	VB	I-VP	O
on	on	IN	B-PP	O
secretions	secretion	NNS	B-NP	O
-LRB-	-LRB-	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
eating	eat	VBG	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
became	become	VBD	B-VP	O
acutely	acutely	RB	B-ADJP	O
hypoxic	hypoxic	JJ	I-ADJP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ABG	ABG	NN	I-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
pH	pH	NN	I-NP	O
of	of	IN	B-PP	O
7.45	7.45	CD	B-NP	O
,	,	,	O	O
pCO2	pCO2	NN	B-NP	O
of	of	IN	B-PP	O
48	48	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
PO2	PO2	NN	I-NP	B-protein
of	of	IN	B-PP	O
36	36	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
family	family	NN	I-NP	I-protein
was	be	VBD	B-VP	O
brought	bring	VBN	I-VP	O
in	in	RP	B-PRT	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
explained	explain	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
recurrently	recurrently	RB	I-VP	O
aspirating	aspirate	VBG	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
critically	critically	RB	B-ADJP	O
ill	ill	JJ	I-ADJP	O
.	.	.	O	O

A	A	DT	B-NP	O
family	family	NN	I-NP	O
meeting	meeting	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
DNR/DNI	DNR/DNI	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
every	every	DT	B-NP	O
attempt	attempt	NN	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
made	make	VBN	I-VP	O
to	to	TO	B-VP	O
bring	bring	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
home	home	NN	I-NP	O
with	with	IN	B-PP	O
hospice	hospice	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
actually	actually	RB	B-ADVP	O
stabilized	stabilize	VBD	B-VP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
acute	acute	JJ	I-NP	O
event	event	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
wean	wean	VB	I-VP	O
from	from	IN	B-PP	O
BiPAP	BiPAP	NN	B-NP	B-protein
to	to	TO	B-PP	O
3	3	CD	B-NP	O
L	L	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
nasal	nasal	JJ	I-NP	O
cannula	cannula	NN	I-NP	O
.	.	.	O	O

Nevertheless	Nevertheless	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
family	family	NN	I-NP	O
understood	understand	VBD	B-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
respiratory	respiratory	JJ	I-NP	O
status	status	NN	I-NP	O
remained	remain	VBD	B-VP	O
tenuous	tenuous	JJ	B-ADJP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
would	would	MD	B-VP	O
likely	likely	RB	I-VP	O
re-aspirate	re-aspirate	VB	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
hospice	hospice	NN	B-NP	O
services	service	NNS	I-NP	O
per	per	IN	B-PP	O
family	family	NN	B-NP	O
request	request	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
diuresed	diurese	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
26	26	CD	B-NP	O
liters	liter	NNS	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

Much	Much	JJ	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
diuresis	diuresis	NN	I-NP	O
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
pharmacological	pharmacological	JJ	B-NP	O
intervention	intervention	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
receive	receive	VB	I-VP	O
minimal	minimal	JJ	B-NP	O
Lasix	Lasix	NNP	I-NP	O
support	support	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
tending	tend	VBG	I-VP	O
towards	towards	IN	B-PP	O
euvolemic	euvolemic	JJ	B-NP	O
or	or	CC	I-NP	O
dry	dry	JJ	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
not	not	RB	O	O
on	on	IN	B-PP	O
any	any	DT	B-NP	O
Lasix	Lasix	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
polyuric	polyuric	JJ	I-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
ATN	ATN	NN	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
resolving	resolve	VBG	I-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabete	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	O
NPH	NPH	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	B-protein
regular	regular	JJ	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
doses	dose	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
decreased	decrease	VBN	I-VP	O
because	because	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
hypoglycemic	hypoglycemic	JJ	B-ADJP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
bleeding	bleed	VBG	B-VP	O
-LRB-	-LRB-	NN	B-NP	B-protein
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
GI	GI	NN	I-NP	O
bleeding	bleed	VBG	B-VP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
of	of	IN	B-PP	O
2.0	2.0	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
review	review	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
medical	medical	JJ	I-NP	O
team	team	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
stroke	stroke	NN	B-NP	O
was	be	VBD	B-VP	O
far	far	RB	I-VP	O
outweighed	outweigh	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Acute	Acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
developed	develop	VBD	B-VP	O
ATN	ATN	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
medication	medication	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
urine	urine	NN	I-NP	O
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
eosinophils	eosinophil	NNS	B-NP	B-cell_type
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
2.1	2.1	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
was	be	VBD	B-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
ATN	ATN	NN	B-NP	B-protein
and	and	CC	O	O
also	also	RB	B-ADVP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
significant	significant	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
is	be	VBZ	B-VP	O
1.7	1.7	CD	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	I-VP	O
trending	trend	VBG	I-VP	O
downwards	downward	NNS	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Thrombocytopenia	Thrombocytopenia	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
thrombocytopenia	thrombocytopenia	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
exacerbated	exacerbate	VBN	I-VP	O
with	with	IN	B-PP	O
heparin	heparin	NN	B-NP	B-protein
products	product	NNS	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
require	require	VB	I-VP	O
platelet	platelet	NN	B-NP	O
transfusions	transfusion	NNS	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
platelet	platelet	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
34	34	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
bright	bright	JJ	I-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
per	per	IN	B-PP	O
rectum	rectum	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
platelet	platelet	NN	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

LFT	LFT	NN	B-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
was	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
was	be	VBD	B-VP	O
of	of	IN	B-PP	O
poor	poor	JJ	B-NP	O
quality	quality	NN	I-NP	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
obese	obese	JJ	I-NP	O
body	body	NN	I-NP	O
habitus	habitus	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
cholestatic	cholestatic	JJ	I-NP	O
picture	picture	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
her	her	PRP$	B-NP	O
DNR/DNI	DNR/DNI	NN	I-NP	O
status	status	NN	I-NP	O
with	with	IN	B-PP	O
hospice	hospice	NN	B-NP	O
services	service	NNS	I-NP	O
pending	pende	VBG	B-VP	O
,	,	,	O	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
workup	workup	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Agitation	Agitation	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
,	,	,	O	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
mourning	mourning	NN	B-NP	O
and	and	CC	O	O
disoriented	disorient	VBN	B-VP	O
,	,	,	O	O
but	but	CC	O	O
responsive	responsive	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
require	require	VB	I-VP	O
Haldol	Haldol	NNP	B-NP	O
and	and	CC	I-NP	O
Ativan	Ativan	NNP	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
also	also	RB	B-ADVP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
interaction	interaction	NN	I-NP	O
.	.	.	O	O

Morphine	Morphine	NN	B-NP	O
was	be	VBD	B-VP	O
adequate	adequate	JJ	B-ADJP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Speech	Speech	NN	B-NP	O
and	and	CC	O	O
swallow	swallow	VB	B-VP	O
evaluation	evaluation	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
failed	fail	VBD	B-VP	O
several	several	JJ	B-NP	O
speech	speech	NN	I-NP	O
and	and	CC	O	O
swallow	swallow	VB	B-VP	O
evaluations	evaluation	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
put	put	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
pudding	pudde	VBG	I-NP	O
thick	thick	JJ	I-NP	O
puree	puree	NN	I-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
palliative	palliative	JJ	B-ADJP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
very	very	RB	I-VP	O
likely	likely	RB	I-VP	O
aspirate	aspirate	VB	I-VP	O
even	even	RB	B-ADVP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Rheumatoid	Rheumatoid	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
96	96	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
22	22	CD	I-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
68	68	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
130/60	130/60	CD	I-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
3	3	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

Exam	Exam	NNP	B-NP	O
is	be	VBZ	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
morbid	morbid	JJ	B-NP	O
obesity	obesity	NN	I-NP	O
,	,	,	O	O
coarse	coarse	NN	B-NP	O
breath	breath	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
right	right	RB	B-ADVP	O
greater	great	JJR	I-ADVP	O
than	than	IN	B-PP	O
left	left	JJ	B-NP	O
,	,	,	I-NP	O
large	large	JJ	I-NP	O
ecchymosis	ecchymosis	NN	I-NP	O
of	of	IN	B-PP	O
varying	vary	VBG	B-NP	O
stages	stage	NNS	I-NP	O
particularly	particularly	RB	B-ADVP	O
at	at	IN	B-PP	O
subcutaneous	subcutaneous	JJ	B-NP	O
injection	injection	NN	I-NP	O
sites	site	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
baseline	baseline	NN	B-NP	O
disorientation	disorientation	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
different	different	JJ	B-ADJP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
usual	usual	JJ	I-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
STUDIES	STUDIES	VBZ	B-VP	O
ON	ON	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
White	White	JJ	B-NP	O
count	count	NN	I-NP	O
11	11	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
33	33	CD	I-NP	O
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
214	214	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	B-protein
134	134	CD	I-NP	I-protein
,	,	,	O	O
sodium	sodium	NN	B-NP	O
148	148	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
111	111	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
40	40	CD	I-NP	I-DNA
and	and	CC	O	O
creatinine	creatinine	NN	B-NP	O
2.1	2.1	CD	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Albuterol	Albuterol	NNP	B-NP	O
nebulizer	nebulizer	NN	I-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
2	2	CD	I-NP	O
h.	h.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
Pepcid	Pepcid	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
NPH	NPH	NN	I-NP	I-protein
4	4	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
SC	SC	NNP	B-NP	O
b.i.d.	b.i.d.	NNP	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	O
regular	regular	JJ	I-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
,	,	,	O	O
Ativan	Ativan	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
to	to	TO	I-NP	O
4	4	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
6	6	CD	I-NP	O
h.	h.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
anxiety	anxiety	NN	I-NP	O
,	,	,	O	O
metoprolol	metoprolol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
morphine	morphine	NN	B-NP	O
immediate	immediate	JJ	I-NP	O
release	release	NN	I-NP	O
15	15	CD	B-NP	O
to	to	TO	I-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
3	3	CD	I-NP	O
h.	h.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
Norvasc	Norvasc	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-PP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
day	day	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
miconazole	miconazole	NN	B-NP	O
2	2	CD	I-NP	O
%	%	NN	I-NP	O
topical	topical	JJ	I-NP	O
powder	powder	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
DuoNeb	DuoNeb	NNP	B-NP	O
q.	q.	NNP	I-NP	O
6	6	CD	I-NP	O
h.	h.	NN	I-NP	O
and	and	CC	I-NP	O
Dulcolax	Dulcolax	NN	I-NP	O
rectal	rectal	JJ	I-NP	O
suppository	suppository	NN	I-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
PR	PR	NN	I-NP	B-protein
daily	daily	RB	B-ADVP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
in	in	IN	B-PP	O
very	very	RB	B-NP	O
poor	poor	JJ	I-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
hospice	hospice	NN	B-NP	O
services	service	NNS	I-NP	O
for	for	IN	B-PP	O
end	end	NN	B-NP	O
of	of	IN	B-PP	O
life	life	NN	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
4-1288265	4-1288265	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
MILBRODT	MILBRODT	NNP	B-NP	O
,	,	,	O	O
JOHN	JOHN	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
GRISSOM	GRISSOM	NNP	B-NP	O
,	,	,	O	O
GUS	GUS	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
1940169	1940169	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
2/10/06	2/10/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
2/10/06	2/10/06	CD	B-NP	O

